LipovaxinS4-EAH not checked

PT Bio Farma · LipovaksinS4-EAH

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“0,5 mL of Middle Dose LipovaxinS4-EAH. Administered twice, 28 days apart”In the company’s words, NCT07647107 on ClinicalTrials.gov
Tested for
Tuberculosis, TB Infection
Main trialPhase 1
“A Phase I, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate Safety and Immunogenicity of Lipovaxin Tuberculosis Vaccine (Bio Farma) in Healthy Populations Aged 18-40 Years in Indonesia”In the company’s words, NCT07647107 on ClinicalTrials.gov
Other names
LipovaksinS4-EAH

Other drugs for Tuberculosis

All 15 drugs for Tuberculosis

Coming up1

Changes1

Last 90 days

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Recruiting Jul 2027 A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow LipovaxinS4-EAH

Following is part of Solo: you see every change to LipovaxinS4-EAH the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in